Thor Medical ASA (FRA:8NN)

Germany flag Germany · Delayed Price · Currency is EUR
0.3560
+0.0095 (2.74%)
Last updated: Dec 5, 2025, 8:03 AM CET
39.61%
Market Cap 127.44M
Revenue (ttm) 8.42K
Net Income (ttm) -4.96M
Shares Out n/a
EPS (ttm) -0.02
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume n/a
Open 0.3560
Previous Close 0.3465
Day's Range 0.3560 - 0.3560
52-Week Range 0.1570 - 0.4050
Beta n/a
RSI 60.94
Earnings Date Feb 26, 2026

About Thor Medical ASA

Thor Medical ASA produces and supplies alpha-particle emitters for cancer therapy in Norway. It develops Ra224, an isotope of radium; Pb-212, a radioactive isotope of lead; and Th-228, a radioactive isotope of thorium. The company was incorporated in 2009 and is headquartered in Oslo, Norway. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2009
Employees 9
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 8NN
Full Company Profile

Financial Performance

Financial numbers in NOK Financial Statements

News

There is no news available yet.